ArticleMolecular biomedicine2026

PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors.

Li Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.